{
    "id": 23004,
    "fullName": "ACOX1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "ACOX1 over exp indicates an over expression of the Acox1 protein and/or mRNA. However, the mechanism causing this over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 51,
        "geneSymbol": "ACOX1",
        "terms": [
            "ACOX1",
            "ACOX",
            "PALMCOX",
            "SCOX"
        ]
    },
    "variant": "over exp",
    "createDate": "06/06/2016",
    "updateDate": "09/19/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6721,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, pancreatic ductal adenocarcinoma patients over expressing ACOX1 demonstrated a greater OS (11.7 mo) when treated with a combination of Masitinib (AB1010) and Gemzar (gemcitabine) compared to Gemzar (gemcitabine) and placebo (5.5 mo) (PMID: 25858497).",
            "molecularProfile": {
                "id": 23676,
                "profileName": "ACOX1 over exp"
            },
            "therapy": {
                "id": 4257,
                "therapyName": "Gemcitabine + Masitinib",
                "synonyms": null
            },
            "indication": {
                "id": 3498,
                "name": "pancreatic ductal adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5787,
                    "pubMedId": 25858497,
                    "title": "A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25858497"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23676,
            "profileName": "ACOX1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}